Introduction
Identification of the pathogenic role of H. pylori in fection has revolutionized the approach toward chronic gastritis, peptic ulcer disease, gastric MALT (mucosa associated lymphoid tissue) lymphoma and gastric can cer. These diseases often result from infection of H. pylori, the accompanying host inflammatory response and the interaction with environmental factors. Eradi cation treatment against peptic ulcer disease is now approved by governmental health care system in Japan. Concerning gastric cancer, persistent histologic gastritis, followed by glandular atrophy, makes up a high back ground for development of gastric cancer and it is in capable by itself of clearing the infection without effec tive combined antibiotic treatment.
Gastric cancer is one of the most common malig nancies in the world, although the incidence and mortality rate has been decreasing in recent decades. Gastric carcinogenesis is multi-factorial, and some en vironmental factors are involved in this process,1 such as excessive intake of salt,2 N-nitroso compounds in foods, and low consumption of fresh fruits and vege tables. H. pylori have been shown to be associated with an increased risk of gastric cancer in a number of epidemiological studies.3-9 On the basis of those epidemiological findings, the International Agency for Research on Cancer, World Health Organization (IARC/WHO) concluded in 1994 that H. pylori infec tion had a causal link to gastric carcinogenesis and is a definite carcinogen in humans. 10 Following the state ments, evidences that H. pylori infection leads to the development of gastric cancer have been accumulated in vivo and in vitro study. In this review, current pro gresses and issues on the animal model using Mongo lian gerbil (MG) and in vitro study of the epithelial cell response to H. pylori infection will be discussed. and the Japanese monkey model demonstrated that H. pylori infection can induce gastric atrophy at 1.5 years after inoculation. However, these animals are too large to conduct cancer experiments, and there are still no reports on the development of gastric cancer in these animal models. Although a mouse model that resem bles human H. pylori chronic gastritis was developed, a specialized H. pylori strain, SS-1 strain, or H. felis were used instead of H. pylori in studies using this model. Hirayama et al. 14 reported for the first time in 1996 that H. pylori could induce gastritis, gastric ulceration and intestinal metaplasia during long-term infection in MG model. In this model, H. pylori was able to colonize in the stomach and induce gastritis at 12 weeks after in oculation, gastric ulceration at 24 weeks after inocula tion, intestinal metaplasia at 24 to 48 weeks after inoc ulation. These histologic characteristics, infiltration of numerous neutrophils and lymphocytes, deep defects of gastric mucosal tissues leading the muscular layer and occurrence of intestinal metaplasia, resembled those of H. pylori infection in humans. Following this report , the MG model began to be used in experiments to study gastric carcinogenesis caused by H. pylori infection.
Development of Gastric Cancer in
In 1998, three papers on the development of gastric cancer using MG models were published in Japan, and In the same year, Watanabe et al. 16 reported that long-term infection with H. pylori alone could induce gastric cancers in MG model at 62 weeks after the in oculation, without administration of any chemical car cinogens. They reported that 10 of 27 H. pylori-infected MGs (37%) developed gastric cancer and that all of them were well-differentiated, intestinal type gastric cancers. Interestingly, they used a very unique strain of H. pylori, named TN2GF4, which was originally isolated from a patient with gastric ulcer, then inocu lated into the stomach of MG several times, and iso lated again and used in their experiments. This strain had vacuolating cytotoxin and cagA gene, and it showed an extremely spiral form. Another key point in their study is that no gastric cancers were observed in the infected animals at 39 weeks or at 52 weeks after inoculation of H. pylori. Honda et al. 17 also reported in the same year that 2 of 5 MGs (40%) infected with H. pylori ATCC 43504 type strain, having vacuolating cytotoxin and cagA gene, developed gastric cancer at 72 weeks after inoculation and that all of the cancers were well-differentiated cancers. However, Hirayama et al. 18 reported that only one gastric cancer had developed in MGs infected with H. pylori ATCC 43504 type strain at 96 weeks follow-up (1.8%) and that the pathology was poorly differentiated adenocarcinoma.
The above-described studies were conducted under different experimental conditions, including different co-treatments of chemical carcinogens, strain differ ences, and different observation periods. These differ ences may have been the reasons for the differences in the incidence of gastric cancer and subtypes of gastric cancer ( Table 1 ). The most troublesome issue is diag nostic criteria for gastric cancer in MGs. In general , gastric cancer in humans is diagnosed on the basis of three histological characteristics: 1) cellular and nuclear atypia, 2) aberrant glandular structure, and 3) invasion . H. pylori-infected MGs sometimes show invasion of glands into the muscular layer and aberrant glands, and these histologic changes are reversed with H . pylori eradication. 19 unfortunately, a lack of genetic information associated with oncogenesis, and there is also a lack of specific antibodies of MGs. These are disadvantages for prog ress of cancer study using this animal model. To over come these bottlenecks, we need genetic information linked to oncogenesis in MGs, such as information on the p53 gene, which might be an appropriate target gene for investigating the oncogenic mechanisms of both types of gastric cancer induced by H. pylori infec tion. Therefore, we aimed to clone the p53 gene of the MG and to establish a yeast assay to detect functional mutation of p53 of the stomach infected by H. pylori. The complete sequence of the p53 cDNA of was deduced. The sequence was found to be 1173 by in length and to encode 391 amino acids. The nucleotide sequence had a 78.8% homology to the human p53 cDNA. The amino acid sequence had a 76.2% homol ogy to the human p53 protein. A novel assay system was established to detect functional mutations of the p53 gene in the stomach of the MGs using the nucleo tide sequence (Fig. 1) . To assess the background per centage of red colonies (mutant-type p53), liver, mus cle, small intestine, brain, tongue, kidney, lung and stomach tissues of a specific pathogen free 5-week-old male MG were tested. All samples showed less than 10% red colonies and had no clonal mutations . To assess the quantification of the yeast functional assay , wild type and mutant-type p53 PCR products from normal liver tissue were mixed at serial ratios . The mixture of wild type and mutant-type p53 PCR products and the gapped pLSGP53 plasmid were co-transformed into yeast yIG397. A highly significant positive correla Fig. 1 are observed not only in cancer but also in the pre cancerous stage, especially in intestinal metaplasia in humans. As described previously, chronic H. pylori in fection in the MG closely resembles that in humans. By using this animal model and the yeast p53 functional assay, it should be possible to elucidate when p53 gene alteration occurs in the process of gastric carcinogenesis in the H. pylori-infected stomach. For efficient preven tion of gastric cancer by H. pylori eradication, the de termination of the "point of no return" is required, that is, the reversible point of genetic alteration in a H. pylori-infected stomach. Sequential examination of the MG model after H. pylori infection may give important clues to verify the reversibility of p53 alteration using the yeast functional assay.
In vitro Epithelial Response infected with H. pylori
Another important approach for the gastric carcino genesis induced by H. pylori infection is to investigate the molecular basis of epithelial cell response after H . pylori infection in vitro. In western epidemiological studies, the persons infected with cagA positive H . pylori strains had high risk for development of gastric cancers, compared with those cagA negative H . pylori strains. 29 Although CagA protein is immunodominant , the function of CagA protein was not clearly eluci dated. Cag pathogenicity island (CagPAI) including cagA gene functions as type 4 secretion machinery , which is a cylinder-like structure and a transfer system of H. pylori components to epithelial cells . 30 In 1999, four groups reported the tyrosine on CagA protein was phosphorylated in epithelial cells and might trigger signal transduction of epithelial cells after the infec tion. 31-34 Therefore, CagA protein is a key molecule to investigate the interaction between the organism and the host. Recently, our group demonstrated that CagA protein was phosphorylated in epithelial cells after transfection of cagA gene and phosphorylated CagA protein formed a complex with SHP-2 type tyrosine phosphatase, which was a key molecule to induce a growth factor-like response in epithelial cells, via phos phorylated tyrosins on CagA protein. 35 Interestingly, transfection of cagA gene induced a hummingbird morphology in epithelial cells and tyrosine phosphory lation and upregulation of SHP-2 type tyrosine phos phatase activity were essential for the induction of hummingbird morphology, which was similar morphol ogy induced by treatment of hepatocyte growth factor (HGF) in epithelial cells. 36 CagA protein, therefore, is responsible for dysregulation of intracellular signaling and cellular morphogenesis. These disruption of signal transduction system and morphology of epithelial cells after H. pylori infection may be associated with gastric carcinogenesis.
